EdgeOne Medical Appoints Michael Denzer as VP of Client Relations to Boost Innovation and Partnerships
EdgeOne Medical, a professional service organization focused on device development service for combination products in the bio-pharmaceutical industry is pleased to announce the appointment of Mr. Michael Denzer as Vice President of Client Relations. This role reflects what matters most…
Innovaccer Unveils AI Solution to Cut Readmissions and Improve Care Outcomes
Innovaccer Inc., a leading healthcare AI company, today announced the launch of a comprehensive, AI-powered Readmissions Management Solution designed to help health systems and providers reduce avoidable readmissions, standardize transitional care management (TCM) protocols, reduce exposure to penalties, and optimize hospital capacity…
Cerus Secures New DoD Award to Advance Trauma Hemorrhage Care
Cerus Corporation (Nasdaq: CERS) announced today that it has been awarded an additional $7.2 million contract amendment by the U.S. Department of Defense (DoD) Industrial Base Analysis and Sustainment (IBAS) program for the development of lyophilized Pathogen Reduced, Cryoprecipitated Fibrinogen…
ImmunoPrecise Appoints Healthcare Data Visionary Jeff Fried to Advisory Board
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment of Jeff Fried to its Advisory Board. LENSai is one of the most…
DeciBio Consulting Names Carl Schoellhammer Partner to Drive Advanced Therapies Strategy
DeciBio Consulting, LLC, a precision medicine-focused strategic consulting and market intelligence firm, has promoted Carl Schoellhammer, Ph.D., to Partner. Carl leads the firm’s advanced therapies practice and serves as Managing Director of the DeciBio BroadOak BioTools Venture Fund, a joint…
CareDx Announces Draft LCD Supporting Coverage for Transplant Rejection Surveillance Testing
CareDx Announces Draft LCD Supporting Coverage for Transplant Rejection Surveillance Testing The Transplant Company – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – announced…
Biocytogen and BeiGene Sign Licensing Deal to Advance Antibody-Based Drug Development
Biocytogen Holdings, a global biotechnology company driving drug discovery with innovative technologies, today announced it has entered into a global licensing agreement for antibody molecules with BeiGene, a global innovator in oncology treatment. BeiGene has previously obtained the authorization to…
Wedgewood Launches Two New Veterinary Councils to Expand Advisory Committee
Wedgewood is excited to announce the expansion and evolution of its Veterinary Advisory Committee to reflect the company’s continued growth and leadership in the veterinary community. As part of this transformation, the company welcomes new members to both the Strategic…
Nanochon announces Health Canada approval for first human study
Nanochon announces Health Canada approval for first human study Nanochon, a Washington, DC, and Baltimore, MD-based orthopedic device biotechnology company developing implants to treat knee cartilage defects, is pleased to announce that it has been granted Health Canada approval for…
Sarepta Therapeutics the leader in precision genetic medicine for rare diseases
Sarepta Therapeutics, the leader in precision genetic medicine for rare diseases, today issued the following statement: Shortly after 2:30 p.m. ET today, Sarepta received an informal request from the U.S. Food and Drug Administration (FDA) to voluntarily halt shipment of…
Minnesota 2025: Medicaid Enrollment Falls, HMOs Lose $1B
Minnesota Health Market Review 2025 Reveals Sharp Declines in HMO Profitability and Medicaid Enrollment It has released Part 1 of the “Minnesota Health Market Review 2025”, marking the 36th edition of this comprehensive report series first launched in 1990. The…
The Texas Health Market Review 2025 The 17th report analyzing this dynamic market Texas Health Market Outlook 2025
The Texas Health Market Review 2025, the 17th report analyzing this dynamic market is now available. It contains 50 pages of data tables, trend graphics and narrative about the health insurers and hospital systems in the state. It describes the…